Fundamentals

Select the financial statements you wish to view below.  The reports below may be viewed on either an annual or quarterly basis.
Data will appear here once earnings are reported.

OTCQXZCOR
All numbers in thousands USD
Period Ending
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
Dec 31, 2015
Total Revenue
30,353
26,136
16,964
22,830
Cost of Revenue
7,447
5,153
3,660
3,271
Gross Profit
22,906
20,983
13,304
19,559
Operating Expenses
Research Development
3,536
14,744
33,759
27,054
Selling General and Administrative
63,568
69,597
58,562
42,763
Non Recurring
--
--
--
--
Others
2,107
2,082
2,006
1,958
Total Operating Expenses
69,211
86,423
94,327
71,775
Operating Income or Loss
(46,305)
(65,440)
(81,023)
(52,216)
Income from Continuing Operations
Total Other Income/Expenses Net
(7,635)
13,747
(1,439)
1,042
Earnings Before Interest And Taxes
(53,258)
(50,805)
(81,023)
(52,216)
Interest Expense
42,196
18,554
13,391
8,702
Income Before Tax
(95,454)
(69,359)
(91,693)
(58,651)
Income Tax Expense
0
0
(1,061)
(718)
Minority Interest
--
--
--
--
Net Income From Continuing Ops
(95,454)
(69,359)
(90,632)
(57,933)
Non-recurring Events
Discontinued Operations
--
--
--
--
Extraordinary Items
--
--
--
--
Effect Of Accounting Changes
--
--
--
--
Other Items
0
0
0
0
Net Income
(95,454)
(69,359)
(90,632)
(57,933)
Preferred Stock And Other Adjustments
--
--
--
--
Net Income Applicable To Common Shares
(95,454)
(69,359)
(90,632)
(57,933)

 

 

CAREERS

Find out more about opportunities with Zyla Life Sciences.

Career Contact
careers@zyla.com

QUICK LINKS

Sign up for Zyla Life Sciences email alerts.

Investor Contact
ir@zyla.com
Media Contact
media@zyla.com

ZYLA LIFE SCIENCES

U.S. Operations
600 Lee Road, Suite 100
Wayne, PA 19087
Tel: 610.833.4200

© Copyright 2019 Zyla Life Sciences
All rights reserved.